Theravance Biopharma, Inc.

NASDAQ:TBPH

Biotechnology

Healthcare
$17.03 -0.42%

-$0.07 today

Market cap
$882.64M
Beta
0.18
P/E (TTM)
7.4
EPS (TTM)
$2.23
52W Low $10.44High $21.03

Volume 10.02M

Average 0.43M

Price history

Theravance Biopharma, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-4.86%

Period high

$20.74

Period low

$13.57

Latest

$17.03

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13D/ASep 25, 2026Sep 25, 2026
S-8 POSSep 24, 2026Sep 24, 2026
4Sep 24, 2026Sep 24, 2026
S-8 POSSep 24, 2026Sep 24, 2026
4Sep 24, 2026Sep 24, 2026
4Sep 24, 2026Sep 24, 2026
S-8 POSSep 24, 2026Sep 24, 2026
S-8 POSSep 24, 2026Sep 24, 2026
4Sep 24, 2026Sep 24, 2026
4Sep 24, 2026Sep 24, 2026
S-8 POSSep 24, 2026Sep 24, 2026
S-8 POSSep 24, 2026Sep 24, 2026
4Sep 24, 2026Sep 24, 2026
S-8 POSSep 24, 2026Sep 24, 2026
4Sep 24, 2026Sep 24, 2026

Competitors

Who does Theravance Biopharma, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about TBPH's filings, answered from its disclosures.

What is the latest TBPH filing?

The latest filing shown is SC 13D/A dated Sep 25, 2026.

How many recent filings does TBPH have?

Intrinsic Alpha currently shows 20 recent filings for TBPH.